illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Winner Medical
Company logo

Winner Medical | Sustainability Performance

https://www.winnermedical.com/

Manufactures and distributes disposable medical products.

1991

China

10,001+ employees

Medical Device

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#6970
Overall
#207
in China
#108
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

52 out of 174

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
BioKangtai

China, Health Care, Biotechnology

Company logo
Shandong Buchang Pharmaceuticals

China, Health Care, Pharmaceuticals

Company logo
INT Medical Instruments

China, Health Care, Medical Device

Market cap

16.5B $, 2026▲86.6% YoY

Revenue

9.0B $, 2024▼8.8% YoY

R&D intensity

3.64% 2024

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Winner Medical Co Ltd, Chinese major medical disposables/personal care (PurCotton brand, COVID19 masks producer), has faced sustained Chinese NMPA enforcement scrutiny over the contested 2024 sustained share price volatility amid the postCOVID Chinese medical disposables customer demand normalization affecting Chinese institutional shareholders amid the broader Chinese medical devices market normalization pressure.
Powered by illuminem

Market cap

16.5B $, 2026▲86.6% YoY

Revenue

9.0B $, FY2024▼8.8% YoY

EBITDA

1.3B $, FY2024▼9.1% YoY

Operating margin

9% Industry: -147▼0.7% YoY

P/E ratio

35.4 Industry: 32▲7.5% YoY

Revenue & EBITDA

$9.0BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

364.9M 2024▼15% YoY

Capex

900.0M 2024▼16.3% YoY

Debt/equity ratio

0.3 Industry: 1▼NaN% YoY

R&D intensity

3.6%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

5.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

11.4

▲ 2.3%

2022

8.2

▼ 6.3%

2023

9.0

▼ 0.3%

2024

14.8

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

33%
Independent Directors

3 out of 9 incl. management

Powered by illuminem

Overall score

75

Environment

98

Social

68

Governance

59

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
image report
Available
image report
Available

Sustainability employees

    Available in
    Scale package

    Access
  • Email
  • Email